Skip to main content
Clinical Trials/NCT02313116
NCT02313116SuspendedNot Applicable

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Diagnostic Photonics, Inc.1 site in 1 country50 target enrollmentStarted: April 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Enrollment
50
Locations
1
Primary Endpoint
Patients With All Positive/Close Margins Correctly Identified With the Device

Study Overview

Brief Summary

This intraoperative study is a prospective study analyzing specimens from fifty subjects. Patients scheduled to undergo breast-conserving surgery will be recruited in accordance with the inclusion and exclusion criteria. The study period per subject is the time it takes to assess the ex vivo breast tissue sample using the study device. Image review will be conducted during surgery and compared to the margin status findings in the post-operative pathology report.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women 18 years of age or older
  • Signed informed consent form
  • Women who have been histologically diagnosed with carcinoma of the breast prior to surgery
  • Patients planning breast preservation and undergoing lumpectomy (partial mastectomy) procedure

Exclusion Criteria

  • Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)
  • Neoadjuvant systemic therapy
  • All T4 tumors
  • Previous radiation in the operated breast
  • Prior surgical procedure in the same quadrant
  • Implants in the operated breast
  • Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

Outcomes

Primary Outcomes

Patients With All Positive/Close Margins Correctly Identified With the Device

Time Frame: 1 week after surgery

Number of Margins With False Positive Device Readings

Time Frame: 1 week after surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials